(firstQuint)Change in Plaque Characteristics With Atorvastatin.

 Patients with acute coronary syndrome (myocardial infarction or unstable angina) who will undergo PCI and have at least one atherosclerotic lesion of >25% stenosis other than culprit lesions of current ACS are enrolled.

 Fibrous cap thickness of a target coronary plaque is evaluated by optical coherence tomography.

.

 Change in Plaque Characteristics With Atorvastatin@highlight

To examine effects of intensive lipid lowering therapy with atorvastatin on stabilization of coronary plaque by using optical coherence tomography (OCT) in patients with acute coronary syndrome.

